Hilary A Robbins
Overview
Explore the profile of Hilary A Robbins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
881
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goodley P, Balata H, Robbins H, Booton R, Sperrin M, Crosbie P
BMJ Oncol
. 2025 Mar;
3(1):e000560.
PMID: 40046247
Objective: Risk prediction models are used to determine eligibility for targeted lung cancer screening. However, prospective data regarding model performance in this setting are limited. Here we report the performance...
2.
Feng X, Alcala K, Guida F, Goldberg M, Zins M, Leleu O, et al.
Lancet Reg Health Eur
. 2025 Feb;
51:101221.
PMID: 39968190
Background: We estimated the potential impact of different eligibility criteria for lung cancer screening in France, to inform a planned national pilot program. Methods: We simulated the French population by...
3.
Onwuka J, Guida F, Langdon R, Johansson M, Severi G, Milne R, et al.
BMJ Oncol
. 2025 Jan;
3(1):e000334.
PMID: 39886123
Objective: Screening high-risk individuals with low-dose CT reduces mortality from lung cancer, but many lung cancers occur in individuals who are not eligible for screening. Risk biomarkers may be useful...
4.
Feng X, Robbins H, Mukeriya A, Foretova L, Holcatova I, Janout V, et al.
Transl Lung Cancer Res
. 2024 Oct;
13(9):2326-2339.
PMID: 39430322
Background: Improved prediction of prognosis among lung cancer patients could facilitate better clinical management. We aimed to study the prognostic significance of circulating proteins at the time of lung cancer...
5.
Onwuka J, Wuraola F, Owoade I, Ogunyemi Y, Di Bernardo M, Dare A, et al.
JCO Glob Oncol
. 2024 Oct;
10():e2400060.
PMID: 39418630
Purpose: The incidence of GI cancers is increasing in sub-Saharan African countries. We described the oncological care pathway and assessed presentation, diagnosis, and treatment intervals and delays among patients with...
6.
7.
Feng X, Goodley P, Alcala K, Guida F, Kaaks R, Vermeulen R, et al.
Lancet Digit Health
. 2024 Aug;
6(9):e614-e624.
PMID: 39179310
Background: Lung cancer risk prediction models might efficiently identify individuals who should be offered lung cancer screening. However, their performance has not been comprehensively evaluated in Europe. We aimed to...
8.
Kearney L, Belancourt P, Katki H, Tanner N, Wiener R, Robbins H, et al.
Ann Intern Med
. 2024 Aug;
177(9):1222-1232.
PMID: 39159457
Background: The recommendation for lung cancer screening (LCS) developed by the U.S. Preventive Services Task Force (USPSTF) may exclude some high-benefit people. Objective: To determine whether alternative criteria can identify...
9.
Orive D, Echepare M, Bernasconi-Bisio F, Sanmamed M, Pineda-Lucena A, de la Calle-Arroyo C, et al.
Arch Bronconeumol
. 2024 Jul;
60 Suppl 2:S67-S76.
PMID: 39079848
Lung cancer remains the leading cause of cancer-related deaths worldwide, mainly due to late diagnosis and the presence of metastases. Several countries around the world have adopted nation-wide LDCT-based lung...
10.